Background: Complex interactions between environmental and genetic factors influence the risk of developing alcohol use disorder (AUD) in humans. To date, studies of the impact of environment on AUD risk have primarily focused on psychological characteristics or on the effects of developmental exposure to ethanol (EtOH). We recently observed that modifying levels of the long-chain x-3 (LC x-3) fatty acid, eicosapentaenoic acid (EPA), alters acute physiological responses to EtOH in Caenorhabditis elegans. Because mammals derive x-3 fatty acids from their diet, here we asked if manipulating dietary levels of LC x-3 fatty acids can affect EtOH-responsive behaviors in mice.
B
OTH GENETIC AND environmental factors strongly influence the risk of developing alcohol use disorder (AUD) (Prescott and Kendler, 1999) . Genetics contribute approximately 50% of the risk, and nongenetic factors contribute the rest (Prescott and Kendler, 1999) . While identification of the genetic variants that confer risk of developing AUD has received considerable effort both in human and animal model studies, very little is understood about specific nongenetic variables that can influence liability. Much of the work in that area has focused on psychological and sociological factors that predispose individuals to AUD, but discrete environmental factors that physiologically influence liability to AUD have not been identified.
A strong predictor of the risk of developing AUD is an individual's acute physiological response to ethanol (EtOH), called the "level of response" (LR). LR is a complex phenotype that is measured in relatively na€ ıve (nontolerant) individuals. A low LR is associated with increased risk of developing AUD (Heath et al., 1999; Schuckit et al., 2001 Schuckit et al., , 2004 . Much effort has been placed on identifying the molecular mechanisms underlying LR using animal models, and variation in the human homologs of genes that affect LR in models are often found to have association with AUD in humans (Grotewiel and Bettinger, 2015) .
Much less is known about the modulation of physiological LR by environmental factors. We previously showed that altering the levels of the long-chain x-3 (LC x-3) polyunsaturated fatty acid eicosapentaenoic acid (EPA) in the nematode Caenorhabditis elegans could modify acute behavioral responses to EtOH (Raabe et al., 2014) . Specifically, we found that animals that are deficient in EPA are unable to develop acute functional tolerance (AFT) to EtOH. In contrast, when we provided supplemental dietary EPA, we could enhance AFT (Raabe et al., 2014) . In C. elegans, EPA is generated from arachidonic acid (AA) through the function of the FAT-1 enzyme, an x-3 fatty acyl desaturase. Vertebrates do not have this enzyme function, so EPA in mammals is derived directly from diet (reviewed in Superko et al., 2013) . Different diets can strongly influence the amount of EPA in human brain tissue which can subsequently influence brain function (Dyall, 2015) . Significant dietary supplementation of the LC x-3 fatty acids EPA and docosahexaenoic acid (DHA) in the form of fish oil is extremely common (Superko et al., 2013 ), yet the impact that these supplements may have on EtOH-responsive behaviors remains unknown.
Given the profound effect of EPA on acute behavioral responses to EtOH in C. elegans, we hypothesized that manipulating levels of dietary LC x-3s in mammals may alter EtOH-responsive behaviors. Here, we demonstrate that C57BL/6J (B6) and DBA/2J (D2) mice fed high or low LC x-3 diets have different behavioral responses to EtOH, and that the effects of these dietary fatty acid levels on different EtOH response phenotypes are modulated by genetic background.
MATERIALS AND METHODS
Male B6 and D2 inbred mice from Jackson Laboratory (Bar Harbor, ME) were delivered at 5 weeks of age and individually housed in polycarbonate ventilated cages (28.5 9 17.5 9 12.5 cm) with corncob bedding on a 12-hour light-dark cycle (lights on at 7 AM). Animals were maintained on the standard Virginia Commonwealth University (VCU) rodent diet (Harlan/Teklad 7012) for 1 week to allow them to acclimate to the environment. After 1 week, the animals were switched to the test diets for the remainder of the experiment.
Specialty diets from Research Diets, Inc. (New Brunswick, NJ), were manufactured to be isocaloric and otherwise identical except for the oil that contributed the fat component. We designed the diets to either augment or deplete polyunsaturated x-3 fatty acids, which we altered by varying the oils that provided the fat calories: We used either safflower oil or a mix of safflower and menhaden (fish) oils. The fatty acids manipulated were the LC x-3 acids, EPA (C20:5) and DHA (C22:6), provided by menhaden oil, and x-6 fatty acids provided by safflower oil. The high LC x-3 fatty acid diet (D04092709R) was modified AIN-93G rodent diet with 1% w/w safflower oil and 9% w/w menhaden oil in ½" pellet form presenting a fatty acid profile containing 14.3% EPA and 9.3% DHA and an x-3/x-6 ratio of 3.3. The low LC x-3 fatty acid diet (D044092701P) was modified AIN-93G rodent diet with 10% w/w safflower oil in ½" pellet form presenting a fatty acid profile containing no detectable LC x-3 EPA or DHA and an x-3/x-6 ratio of 0.002 (the small amount of x-3 provided is in the form of linolenic acid). The standard grain-based diet used by VCU (Harlan/Teklad 7012) has a x-3/x-6 ratio of 0.1, where the x-3 provided is linolenic acid. The typical North American diet, which is low in LC x-3s, has a x-3/x-6 ratio of 0.06 to 0.1 (Kris-Etherton et al., 2000) .
Please note that most standard rodent diets provide x-3 fatty acids only in the form of the vegetable-based x-3 fatty acid, linolenic acid (C18:x3). Linolenic acid is a short-chain polyunsaturated fatty acid, which is not functionally equivalent to either of the LC x-3 fatty acids, EPA or DHA (C22:x3). Therefore, when making comparisons between diets for x-3 fatty acids concentrations, linolenic acid concentrations should not be used as a substitute for EPA or DHA.
Each diet was stored under argon gas at À80°C to minimize oxidation. Regulated diet (~30 g) was placed into the appropriate cage once per week. Mouse weight (g) and the remaining weight of the food (g) were recorded weekly to obtain food consumption and body weight measures. Leftover food was discarded.
Fatty Acid Extraction and Quantification
EPA, DHA, and the x-6 fatty acid AA were measured using a modification of a method previously described (Di Marzo et al., 2000) . A 7-point calibration curve with a range of 100 to 10,000 ng/ ml and a 0 ng/ml control were prepared in parallel with each batch of samples. Fifty nanograms each of deuterated internal standards, EPA-d5, DHA-d5, and AA-d5 (Cayman Medical Company, Ann Arbor, MI) was added to each experimental sample (0.1 g of tissue or 0.1 ml of fluid), calibration sample, and 0 ng/ml control. One milliliter chloroform/methanol (2:1, v/v) was added to the samples. Tissue samples were then homogenized using an IKA-Labortechnik Ultra-Turrax T25 Ò homogenizer (Wilmington, NC). Two-tenths milliliters of 0.73% sodium chloride was added to each sample prior to mixing and centrifugation. The chloroform was collected and reserved. The aqueous phase was then extracted once more with chloroform/methanol, and the chloroform fractions for each sample were pooled and evaporated to dryness under nitrogen. These extracts were reconstituted with 100 ll mobile phase and placed in autosampler vials for high-performance liquid chromatographytandem mass spectrometry (HPLC/MS/MS) analysis.
The HPLC/MS/MS analysis was performed on an Applied Biosystems 3200 Q trap with a turbo V source for TurbolonSpray or a Sciex 6500+ (Ontario, Canada) attached to a Shimadzu SCL HPLC system (Kyoto, Japan) controlled by Analyst 1.4.2 software (Sciex, Ontario, Canada). Chromatographic separation was performed on Discovery Ò HS C18 Column (15 cm 9 2.1 mm, 3 lm; Supelco, Bellefonte, PA).
Determining the Effects of Dietary Manipulation on x-3 and x-6 Concentrations
After 1 week of acclimation to the vivarium, mice were separated into diet treatment groups (n = 20/genotype/diet) for a minimum of 9 weeks in order to stabilize blood fatty acid levels. We measured blood concentrations of the LC x-3 fatty acids DHA and EPA and the x-6 fatty acid AA after the animals had been maintained on the experimental diets for 9 weeks. Blood was collected from the submandibular vein (150 ll). Behavioral testing began after 9 weeks of experimental diet feeding. Mice remained on the assigned diets ad libitum throughout the experiments.
EtOH-Induced Locomotor Activity
Mice were tested after 9 to 11 weeks on the experimental diets (n = 20/diet/genotype). Mice were habituated to intraperitoneal (i.p.). injections with normal saline (0.9% w/v) for 2 days and habituated to the locomotor activity boxes (Omnitech Electronics, Inc, Columbus, OH) for 5 minutes on day 1 and 15 minutes on day 2. On the test day, mice were habituated to the testing room for 1 hour and habituated to the locomotor activity box for a 15-minute session, injected with 1.5 g/kg EtOH, 2.0 g/kg EtOH (10% w/v i.p. in 0.9% saline), or 0.9% saline and immediately tested for locomotor behaviors in a 15-minute test session. For blood EtOH concentration (BEC) measurements, blood was collected by submandibular bleed immediately upon removal from the locomotor boxes, approximately 15 minutes after the EtOH injection.
Intermittent EtOH Consumption
B6 mice began intermittent 2-bottle choice drinking in the home cage beginning in week 14 (day 101) of diet treatment for a total of 20 EtOH sessions and D2 mice began drinking in week 13 (day 94) of experimental diet treatment for a total of 19 EtOH sessions. Mice (n = 20/diet) were given intermittent access to 2 bottles containing 15% v/v EtOH in tap water or tap water alone in 15-ml conical tubes with rubber stoppers fitted with a ball-bearing sipper tube. EtOH bottles were placed on cages every other day on alternating sides at the beginning of the dark cycle. Water and diet treatment were present ad libitum. Cages without animals but with water and 15% v/v EtOH bottles were used to correct for evaporation and bottle leakage.
Loss of Righting Reflex
B6 mice (n = 11 high and 13 low LC x-3 diet) were tested on day 136 and 150 of dietary treatment. D2 mice (n = 18 high and n = 18 low LC x-3 diet) were tested on day 137 and 138 of dietary treatment. B6 and D2 mice were administered 3.8 g/kg EtOH (18% v/v in 0.9% saline, i.p.) to test the effects of a sedating dose of EtOH. We used the cylindrical apparatus for loss of righting reflex (LORR) establishment as described in Ponomarev and Crabbe (2002) . LORR is considered to be established after a mouse cannot right itself from the supine position after 5 seconds; this is tested with 2 consecutive turns of the cylindrical apparatus spaced 2 to 3 seconds apart. LORR onset was calculated as the time from EtOH administration to the time at the end of the 5-second period that the mouse remained in the supine position. Immediately after LORR onset, the mice were placed in the supine position in the V-cut of the feeding trough of empty feeding trays. Time to recovery of the righting reflex (LORR duration) was determined when the mouse righted to the prone position, placing all 4 paws on the feeding trough twice within a 30-second period. Blood (150 ll) was collected immediately after regaining the righting reflex. One B6 high x-3 mouse was excluded due to probable misplaced EtOH injection.
Analysis of EtOH Metabolism
An EtOH time course for 3.8 g/kg EtOH (18% v/v in 0.9% saline, i.p.) was conducted on days 166 and 170 of diet treatment for B6 mice and days 169 and 170 of diet treatment for D2 mice. After EtOH administration and the LORR were established as described in the LORR procedure, blood samples (20 ll) were collected at 15-, 30-, 60-, and 90-minute intervals.
BEC Determination
Blood was collected in heparinized tubes via retro-orbital or submandibular bleeds. Samples were stored at À80°C and then measured using headspace chromatography. The blood EtOH content was determined using a modified method routinely employed for the analysis of clinical and forensic samples for EtOH (Poklis et al., 2017) . A 7-point calibration curve was prepared from 100 to 8,000 mg/l EtOH. Analysis was performed using a Tekmar HT3 headspace autosampler (Mason, OH) attached to a Shimadzu 2014 Gas Chromatograph with a flame ionization detector. The chromatographic separation was performed on a RTX-BAC1, 30 m 9 0.32 mm id 9 1.80 lM column (Restek Corp, Bellefonte, PA). The limit of detection for all volatiles was 50 mg/l with a determined linear range of 50 to 8,000 mg/l for the assay.
Tissue Harvest B6 (n = 12 high LC x-3 diet, n = 13 low LC x-3 diet) mice were sacrificed on day 208 of dietary treatment. D2 (n = 20 high LC x-3 diet; n = 18 low LC x-3 diet) mice were sacrificed on day 241 of dietary treatment. At the time of harvest, subcutaneous, gonadal, mesenteric, and intrascapular brown fat tissues were weighed and recorded. The heart, liver, and microdissected brain regions were collected and stored at À80°C for future analysis. Body metrics including body weight (g), body density, and body length (cm) were recorded in order to determine the percentage of body fat relative to mouse body mass. We determined body density by dividing dry body weight by the dry body weight minus wet/immersed body weight. We assumed that the residual volume of gas in the body of the mouse was small and was similar between subjects.
Statistics
We analyzed B6 and D2 data separately because we were interested in the relative changes due to dietary manipulation within each strain, and we did not compare data between strains. For fatty acid modulation, Student's t-tests were used to compare fatty acid levels between diets (high LC x-3 vs. low LC x-3). Two-way repeated measures repeated measures analyses of variance (RM ANOVAs) were used for EtOH locomotor activation assays within each diet with EtOH dose (saline, 1.5 and 2.0 g/kg) as a factor and time (5, 10, and 15 minutes) as the RM. For EtOH consumption and preference, 2-way RM ANOVA was used between diet groups with a Tukey post hoc test. Two-tailed, unpaired t-tests were used to calculate significance for the LORR assay. Two-way RM ANOVAs were used for EtOH pharmacokinetic studies. For all analyses, we used SigmaPlot (version 13; Systat Software, Inc., San Jose) and significance was set at p < 0.05.
RESULTS

Dietary Manipulation Strongly Influenced x-3 and x-6 Fatty Acid Profiles in B6 and D2 Mice
Preliminary testing suggested that blood fatty acid concentrations stabilized after 8 weeks of dietary treatment, so we tested the fatty acid profile of animals after 9 weeks on the experimental diets. We found that the dietary manipulation significantly altered EPA, DHA, and AA concentrations relative to our initial measurements in both B6 and D2 mice. In B6 mice on a high LC x-3 diet, EPA and DHA concentrations were significantly increased while AA concentrations were decreased as compared to B6 mice on a low LC x-3 diet that significantly decreased EPA and DHA concentrations (Table 1 ; p < 0.001 for all measures). Similarly, in D2 mice on high LC x-3 diet, EPA and DHA concentrations were significantly higher and AA concentrations were significantly lower than D2 mice on a low LC x-3 diet (p < 0.001).
Dietary LC x-3s Influenced EtOH-Induced Locomotor Activation in B6 and D2 Mice
We asked 2 questions about the effects of dietary LC x-3 levels on locomotion. First, we asked if basal locomotion was different in animals maintained on the 2 diets by measuring locomotion for 15 minutes after an i.p. saline injection. We found that the diets did not alter the basal locomotor activity relative to each other in either the B6 or D2 strains, B6:
Second, we examined EtOH-induced locomotor activation as an initial measure of LR to EtOH in animals in which LC x-3 levels had been manipulated. EtOH can induce acute locomotor activation in a genotype-dependent manner in mice; D2 animals demonstrate a more robust activation response than B6 animals (Dudek et al., 1991; Rose et al., 2013) . We tested animals for 15 minutes after an injection of 0, 1.5, or 2.0 g/kg EtOH. We found that dietary manipulation influenced EtOHinduced locomotor activation in both strains (Fig. 1) .
Dietary LC x-3 levels dramatically altered EtOHinduced locomotor activation responses in B6 mice. In agreement with previous reports that B6 animals do not demonstrate significant locomotor activation (Dudek et al., 1991; Rose et al., 2013) , we found that B6 mice maintained on the high LC x-3 diet were not activated in this assay (Fig. 1A) . Neither EtOH dose was significantly different than saline, and there was no main effect of dose on B6 mice, F(2, 59) = 1.367, p = 0.280, or interaction between dose and time, F(4, 59) = 0.873, p = 0.490. As expected, locomotor activity did increase over time, F(2, 59) = 47.130, p < 0.001.
In marked contrast, we found that B6 animals on the low LC x-3 diet expressed strong locomotor activation at both doses of EtOH (Fig. 1B) . Two-way RM ANOVA revealed significant main effects of dose, F(2, 59) = 19.989, p < 0.001, and time, F(2, 59) = 108.926, p < 0.001, as well as interactions between them, F(4, 59) = 3.473, p = 0.018. Locomotor activity in saline-treated mice was significantly lower than EtOH-treated mice, but the effects of the 2 EtOH doses did not differ from each other. EtOH locomotor activation is lower in B6 and D2 mice fed a high x-3 diet. Mean AE SEM cumulative locomotor activity of B6 mice on (A) high x-3 diet or (B) low x-3 diet after saline, or EtOH at 1.5 and 2.0 g/kg. Mean AE SEM cumulative locomotor activity of D2 mice on (C) high x-3 or (D) low x-3 diet after saline, or EtOH at 1.5 or 2.0 g/kg. *p < 0.05 versus saline, main effect of diet by RM ANOVA. D2 mice have been reported to exhibit a more robust EtOH-induced locomotor activation than B6 mice (Dudek et al., 1991; Rose et al., 2013) , and we found that D2 mice demonstrated significant locomotor activation at both EtOH doses regardless of diet (Fig. 1C,D) . Interestingly, however, D2 mice on the high LC x-3 diet had a less robust activation compared with mice on the low LC x-3 diet. In D2 mice on the high LC x-3 diet, we found significant main effects of dose, F(2, 59) = 6.943, p = 0.006, and time, F(2, 59) = 125.433, p < 0.001, and significant interactions between the two, F(4, 59) = 4.053, p < 0.001. EtOH-induced locomotor activity at 1.5 g/kg EtOH was not significantly different than 2.0 g/kg EtOH at any time point, indicating that, like in the B6 mice, dietary fatty acid levels had strong effects on the behavioral responses to EtOH. Locomotor activity at both EtOH doses was significantly greater than saline.
In D2 mice on a low LC x-3 diet, we noted a dose-and time-dependent increase in locomotor activity (Fig. 1D) . Two-way RM ANOVA revealed significant main effects of dose, F(2, 59) = 18.046, p < 0.001, and time, F(2, 59) = 148.959, p < 0.001, and significant interactions between the two, F(4, 59) = 14.174, p < 0.001. EtOH dosedependently increased locomotor activity over saline-treated controls through the course of the assay.
Dietary LC x-3 Levels Did Not Affect Metabolism of 1.5 g/ kg or 2 g/kg of EtOH
We determined BECs at 15 minutes after injection (Table 2) . We found that BECs in B6 mice were not significantly different between diets, F(1, 39) = 1.124, p = 0.264, but, as expected, were greater in the mice injected with 2.0 g/ kg compared with the 1.5 g/kg dose, F(1, 39) = 26.925, p < 0.001. No significant interactions between diet and dose were found, F(1, 39) = 0.0778, p = 0.782.
We also found that BEC taken 15 minutes after the EtOH injection (Table 2) was not significantly different in D2 mice on the high or low LC x-3 diets, F(1, 39) = 2.453, p = 0.126. As expected, there was a significant difference in BEC between EtOH doses, F(1, 39) = 14.454, p < 0.001, where the 1.5 g/kg EtOH dose gave lower BECs than the 2.0 g/kg dose. EtOH dose and diet did not significantly interact, F(1, 39) = 0.297, p = 0.589.
Dietary LC x-3 Levels Influenced EtOH Consumption in EtOH-Preferring B6 Mice, but Did Not Change Consumption in EtOH Nonpreferring D2 Mice
We measured EtOH consumption and preference using the intermittent access 2-bottle choice paradigm in which the animals were given the choice to consume 0% or 15% (v/v) EtOH every other day. Water was always available. We found that dietary LC x-3 levels had a significant effect on EtOH consumption in B6 mice: B6 mice on the high LC x-3 diet consumed more EtOH than B6 mice on the low LC x-3 diet ( Fig. 2A) . Two-way RM ANOVA revealed a main effect of diet, F(1, 799) = 4.156, p = 0.049. On average, EtOH intake in B6 mice on a high LC x-3 diet was 9.3 g/kg, while mice on a low LC x-3 diet consumed 6.99 g/kg EtOH. We observed a main effect of time, F(1, 19) = 4.267, p < 0.001, where the first day of EtOH intake was significantly greater than most other days (d9, d11, d15, d27, d35, and d39), but there were no significant interactions between diet and day, F(19, 799) = 1.325, p = 0.159. EtOH preference (Fig. 2B) showed a trend toward significance for diet, F(1, 797) = 2.992, p = 0.092, and there was a significant effect of day where day 1 preference was greater than most other days (d3, d7, d9, d11, d13, d15, d19, d23, d27, d35, and d39). Total fluid consumed (Fig. 2C ) was also greater in B6 mice on the high LC x-3 diet as compared to the low LC x-3 diet, F(1, 797) = 5.848, p = 0.020. Significant effects of day were also found for total fluid intake, F(19, 797) = 5.696, p < 0.001, where fluid consumption on day 35 and day 39 was lower than all other days. D2 mice consumed less EtOH than B6 mice, consuming only 2.4 g/kg EtOH in 24 hours using an intermittent 2-bottle choice assay (Fig. 2D) , and their EtOH intake was not significantly altered by diet, F(1, 711) = 0.697, p = 0.409. Main effects of day were significant, F(17, 711) = 5.065, p < 0.001, where EtOH intake on days 7 and 9 was greater than most other days. Interaction between day and diet was not significant, F(17, 711) = 0.977, p = 0.459. Likewise, EtOH preference (Fig. 2E) was not significantly different between diets, F(1, 711) = 1.38, p = 0.247. We did note significant main effects of day, F(17, 711) = 5.627, p < 0.001, with days 7 and 9 EtOH preference greater than most other days. Interactions between diet and day were not significant, F(17, 711) = 0.926, p = 0.543. Total fluid consumed (Fig. 2F ) was also not different in mice on the high LC x-3 diet as compared to mice on the low LC x-3 diet, F(1, 711) = 0.550, p = 0.463. We observed significant effects of day for total fluid intake, F(17, 711) = 6.927, p < 0.001, where fluid consumption on days 27, 29, and 33 was higher than most other days.
Sensitivity to a Sedating Dose of EtOH Is Dependent on Dietary LC x-3 Levels in D2 Mice, but Not in B6 Mice
We tested the sedative-hypnotic effects of EtOH using the LORR assay. The sensitivity of B6 mice to a sedating/hypnotic dose was not significantly altered by LC x-3 diet (Fig. 3) .
Neither the latency to lose the righting reflex (Fig. 3A , p = 0.500) nor the duration of LORR was different between diets (Fig. 3B , p = 0.735). Mirroring the behavioral data, diet did not interact with BEC upon regaining the righting reflex (high LC x-3 = 386 AE 22 mg/dl and low LC x-3 = 390 AE 16.4 mg/dl, p = 0.907). We found a very different result in D2 mice, in which dietary LC x-3 levels significantly influenced sensitivity to a sedating/hypnotic dose of EtOH. The latency to lose the righting reflex was not altered by diet (Fig. 3C , p = 0.132). However, the duration of LORR was significantly greater in mice consuming the high LC x-3 diet (Fig. 3D , p = 0.035), suggesting these mice are more sensitive to EtOH, or have a decreased development of AFT to EtOH than mice on the low LC x-3 diet. D2 mice fed the high LC x-3 diet had lower BEC (366.1 AE 8.3 mg/dl) when they recovered the righting reflex compared to D2 mice fed a low LC x-3 diet (404.9 AE 5.5 mg/dl, p = 0.0004). These data indicate that the dietary manipulation of LC x-3 fatty acids can strongly affect EtOH sensitivity.
EtOH Metabolism Is Influenced by Dietary LC x-3s in D2 Mice, but Not in B6 Mice
We conducted a BEC time course using a high EtOH dose (3.8 g/kg, i.p.), and found that EtOH metabolism was not different between B6 mice on the high or low LC x-3 diet (Fig. 4A, F(1, 110) = 0.149, p = 0.703). As expected, BEC significantly decreased over time, F(3, 110) = 31.815, p < 0.001, and we did not find significant interactions between diet and time, F(3, 110) = 0.115, p = 0.951.
We did, however, find that diet significantly altered EtOH metabolism in D2 mice. BECs were greater in D2 mice on the high LC x-3 diet as compared to the low LC x-3 diet (Fig. 4B, F(1, 75) = 7.106, p = 0.016), primarily driven by differences at the 15-and 30-minute time points. There was a significant effect of time, F(3, 75) = 8.077, p < 0.001, but interactions between diet and time were not significant, F(3, 75) = 0.836, p = 0.481.
Terminal Body Fat Composition Is Different in D2 Mice on High LC x-3 Diet
At the termination of the study, we collected wet and dry body weights to estimate differences in body density. We also Fig. 2 . The level of dietary x-3 fatty acids alters EtOH intake in B6, but not D2 mice. Daily EtOH intake (A), preference (B) and total fluid intake (C) in B6 mice. Daily EtOH intake (D), preference (E), and total fluid intake (F) in D2 mice. EtOH intake and total fluid were greater in B6 mice on a high x-3 diet relative to B6 on a low x-3 diet. EtOH preference showed a trend toward increased preference in B6 mice on a high x-3 diet relative to B6 on a low x-3 diet. EtOH intake, preference, and total fluid intake were not altered by diet in D2 mice. Data are presented as mean AE SEM.*p < 0.05, main effect of diet by 2-way RM ANOVA. A B C D Fig. 3 . Sensitivity to a high dose of EtOH is greater in D2 mice on a high x-3 diet. Latency to lose the righting reflex (in seconds) in (A) B6 and (C) D2 mice was not significantly altered by diet. The duration of sleep time (in minutes) was significantly greater in D2 mice (D) on high x-3 diet relative to D2 mice on low x-3 diet, but not in B6 mice (B). Data are reported as mean AE SEM. *p < 0.05 by t-test in high versus low x-3 diet.
collected 4 regions of fat pad deposition: subcutaneous, gonadal, mesenteric, and intrascapular brown fat to estimate relative differences in fat deposition in animals fed high and low LC x-3 fatty acid diets. Given that the diets were matched to be isocaloric and contain similar amounts of total fat, we did not expect to see differences in body weight or fat composition. In B6 mice, none of the measures, body weight, body density, and all fat pad depositions, was significantly altered by diet (Fig. 5, p > 0.05) . In D2 mice, however, body weight and body length (nose-anus) were slightly but significantly lower in mice on the low LC x-3 diet (Fig. 5 , p = 0.044 and p = 0.047, respectively) relative to mice on the high LC x-3 diet, suggesting that mice in the low LC x-3 group were slightly smaller in body size. White fat pads and body density were not significantly different between D2 mice fed either diet (p > 0.05). Interestingly, intrascapular brown fat was greater in D2 mice on the high LC x-3 diet compared with mice on the low LC x-3 diet (p = 0.006).
DISCUSSION
There is much interest in identifying factors that predispose individuals to developing AUD. While genetic variation plays an important role, very little is understood about nongenetic factors that alter the molecular effects of alcohol, and thereby influence the propensity to abuse alcohol. In this study, we investigated the impact of manipulating the levels of dietary LC polyunsaturated x-3 fatty acids on acute EtOH sensitivity and EtOH consumption in 2 genetically divergent mouse strains with different EtOH response phenotypes. We found that altering only the levels of LC x-3 fatty acids and x-6 fatty acids in otherwise identical diets could cause significant alterations in several behavioral responses to EtOH. Furthermore, using the B6 and D2 strains of mice, we found that diet could interact with the genetic background to significantly alter different phenotypic measures of acute EtOH sensitivity and, importantly, voluntary EtOH consumption (Table 3) .
Altering dietary LC x-3 levels had quite different effects on different EtOH response phenotypes in the 2 strains of mice. Low dose EtOH can cause locomotor activation in a manner that is modulated by genotype (Dudek et al., 1991; Rose et al., 2013) . We found that in both strains, animals fed the high LC x-3 diet had less EtOH-induced locomotor activation than animals fed the low LC x-3 diet. As has been previously reported, we observed that D2 mice displayed High-ω3 Low-ω3
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Fig. 5. D2 mice on high x-3 diet have more intrascapular brown fat. Mean AE SEM of body weight (A, E), body density (B, F), body length (C, G), and fat pads (D, H) in B6 (A-D) and D2 mice (E-H). Body weight, body length, and intrascapular brown fat were lower in D2 mice on low x-3 diet (E-H). *p < 0.05 by t-test in high versus low x-3 diet.
greater EtOH-induced locomotor activity than B6 mice (Dudek et al., 1991) . Dietary LC x-3s modified this response; at low locomotor-activating doses of EtOH, D2 mice on the diet depleted in LC x-3 fatty acids displayed a dose-dependent increase in locomotor activity after acute EtOH. This is similar to the reported behavior of D2 mice on standard laboratory chow (Rose et al., 2013) . In D2 mice on the high LC x-3 diet, however, while we did observe EtOHinduced locomotor activation, the mice did not display a dose-dependent increase in locomotor activity. We interpret this blunting to mean that the maximal activating response was achieved at low-to-moderate EtOH doses in D2 animals fed the high LC x-3 diet, or, alternatively, that those animals are more sensitive to the sedating effects of EtOH at lower doses, masking any additional activating effects. In either case, these data suggest that high levels of LC x-3 fatty acids decrease sensitivity to the acute locomotor-activating effects of EtOH in D2 mice.
Dietary LC x-3 levels also tuned the acute EtOH sensitivity of B6 mice. Interestingly, in B6 mice, which do not always display robust EtOH-induced locomotor activation (Melon and Boehm, 2011; Rose et al., 2013) , we found that animals on a diet depleted in LC x-3 fatty acids demonstrated convincing EtOH-induced locomotor activation, but not in a dose-dependent manner. In contrast, B6 mice on a high LC x-3 diet demonstrated no EtOH-induced locomotor activation. These data suggest that depleting LC x-3 fatty acids decreased the animals' sensitivity to the depressing effects of EtOH, revealing the locomotor-activating effects at the 1.5 g/kg dose. These data are consistent with the results of a recent study in which fish oil supplements were reported to attenuate cocaine locomotor sensitivity in rats on a high-fat diet (Serafine et al., 2016) . These differences in responses at low, locomotor-activating EtOH doses between animals on the experimental diets are not easily explained by simple differences in EtOH metabolism at this early time point. When measured immediately after the locomotor assay, we could not detect a difference in blood EtOH levels between animals on the different diet treatments.
We tested the effects of dietary LC x-3 levels on the response to a high, sedating dose of EtOH in the LORR, and found that here, too, there were differences in the effects of dietary manipulation of fatty acid levels in the 2 strains of mice. We found that while dietary manipulation had no effect on the LORR duration in B6 mice, D2 mice fed high LC x-3 diet took significantly longer to recover the righting reflex than D2 mice on the low LC x-3 diet, and the BEC upon waking was lower in the high LC x-3-fed mice. These observations, combined with the locomotor activation data, suggest that the high LC x-3 diet enhanced sensitivity to EtOH (i.e., EtOH sedation) in the D2 strain.
Intriguingly, when we examined a time course of EtOH metabolism after a 3.8 g/kg injection, we found that the diets also influenced BECs in D2 mice. Animals fed the high LC x-3 diet had slightly greater BECs early (at 15 and 30 minutes) during the EtOH time course, but were similar at the latter times compared with animals fed the low LC x-3 diet. This suggests that there was a more rapid rate of EtOH elimination in D2 mice on high LC x-3 diet. We were particularly struck by this result, because in human genetics studies, a commonly replicated genetic predictor of susceptibility to develop AUD is allelic variation in genes that regulate EtOH metabolism (Edenberg and Foroud, 2014) . Our data point to the possibility that dietary LC x-3 fatty acid levels may influence EtOH metabolism and thereby are good candidates for influencing alcohol dependence liability.
We found that animals on the 2 diets appeared to grow equally well, because their sizes, body weights, and overall body fat at the end of the experiment did not differ between dietary treatments. To determine whether there was a more subtle difference in fat deposits, we examined the fat pads in the animals. In almost all cases, there was no difference in the weight of fat pads between animals on the 2 diets. We did find, however, that D2 animals maintained on the high LC x-3 diet had more intrascapular brown fat. Because brown fat is involved in metabolism, this may point to a possible explanation for the faster rate of EtOH metabolism in these mice. Future experiments will be needed to determine how LC x-3 fatty acid content and fat content/deposition play a role in EtOH sensitivity and metabolism.
Ultimately, our goal was to ask if modulating levels of dietary LC x-3 fatty acids could modify voluntary EtOH consumption in mammals. We found that B6 mice drank more EtOH and demonstrated a trend for higher EtOH preference if they were maintained on a diet high in LC x-3 compared with B6 mice on a diet depleted of LC x-3s. Total fluid intake was also slightly increased in B6 mice on a diet high in LC x-3. Importantly, this increased total fluid consumption is driven by increased drinking from the EtOH bottle by B6 mice on a high LC x-3 diet as there was a significant increase in the volume of EtOH consumed (p = 0.024), but not a significant difference in the volume of water consumed (p = 0.425). D2 mice tend not to drink EtOH due to its taste (McCool and Chappell, 2014) , and, indeed, we found that D2 mice did not drink large volumes of EtOH in the 2-bottle choice test and diet did not modify EtOH intake or preferences. Data are reported for mice on the high x-3 diet compared with mice on the low x-3 diet.
BEC, blood EtOH concentration; LORR, loss of righting reflex; RORR, regaining of righting reflex.
It is interesting to consider how these sensitivity phenotypes correspond to the original observations in C. elegans, where EPA levels acted like a rheostat to modify AFT, which is reasonably similar to the murine LORR assay. In worms, more EPA enhanced AFT (decreased the sedation time), and loss of EPA inhibited AFT (increased sedation time) (Raabe et al., 2014) . In contrast, here we show that in the D2 strain of mice, higher levels of LC x3s increased sedation time. One intriguing possibility is that the DHA in these studies, which was not tested in C. elegans, had important and opposite effects on EtOH sensitivity than did EPA. However, while we cannot yet reconcile these disparate results, it is not without precedent for the direction of effect of drugs in different organisms to be different. For example, in humans, opioids are strong behavioral depressants, whereas in rodents, opioids cause robust locomotor activation (Katz, 1982) . LC x-3 fatty acids are derived from the diet in mammals, and there are significant differences in LC x-3 levels in humans (reviewed in Superko et al., 2013) . Many people routinely use fish oil supplementation to increase EPA and DHA levels, and this can have a significant effect on plasma LC x-3 levels (Superko et al., 2013) . Increasing evidence points to important roles for LC x-3 fatty acids in neurobiological disorders such as bipolar disorder (reviewed in Saunders et al., 2016) and alcoholism.
This study clearly demonstrates that dietary supplementation of LC x-3 fatty acids can both modify acute behavioral responses to EtOH and can influence EtOH drinking in mice. These data add to a growing appreciation that LC x-3 fatty acids play important roles in neurobiological conditions across phyla. For example, in rats, addition of the LC x-3 fatty acid DHA reduced alcohol consumption in a stress-reactive genetic animal model of bipolar disorder and comorbid alcoholism, and in alcohol-preferring P rats (Le-Niculescu et al., 2011) . In humans, dietary supplementation of LC x-3 fatty acids was shown to decrease the anxiety and cortisol levels in abstinent alcoholics in a residential treatment facility (Barbadoro et al., 2013) .
However, the complex relationship between LC x-3 fatty acid levels and EtOH consumption is not yet fully understood. There are some suggestions that LC x-3 levels are themselves modulated in response to EtOH consumption. Increased levels of DHA were found in the umbilical cord blood of infants exposed to EtOH during early gestation (Denkins et al., 2000) , and dysregulation of LC x-3 levels was correlated with alcoholic liver injury in very heavy drinking males seeking treatment (Vatsalya et al., 2016) . In other studies, relationships between LC x-3 levels and alcohol drinking are observed, but whether LC x-3 levels influence alcohol drinking, or alcohol drinking modulates LC x-3 levels is less clear. In healthy subjects in the human IMMI-DIET study, higher alcohol consumption was associated with higher blood levels of both EPA and DHA in women, and with higher blood levels of EPA in men (di Giuseppe et al., 2009) . In postmortem samples of human orbitofrontal cortex, higher levels of DHA were correlated with a greater severity of alcohol abuse (McNamara et al., 2008) .
A relationship between diet and EtOH response phenotypes has been observed previously. Recently, Marshall and colleagues (2015) directly tested the possibility that differences in standard laboratory diets may play a role in intralaboratory variability in EtOH response phenotypes, particularly in measures of voluntary consumption. While the important components of the diets were not identified, this study clearly demonstrated that diet alone can modify both EtOH consumption and acute LR phenotypes in B6 mice.
Our data demonstrate that the levels of dietary LC x-3 fatty acids alter mechanisms in B6 and D2 mice to modify EtOH sensitivity and, in B6 mice, to modulate EtOH drinking. In humans, such changes in EtOH responses may have a meaningful impact on the risk of developing alcohol dependence (Heath et al., 1999; Schuckit et al., 2001 Schuckit et al., , 2004 . Importantly, we found that there was a significant impact of genetic background on the effects of dietary manipulation of LC x-3 levels. While EtOH response phenotypes of both B6 and D2 mice were modified by dietary LC x-3 levels, the individual phenotypes affected were somewhat different in the 2 different genetic backgrounds. This raises the intriguing possibility that the influence of the interaction between environmental and genetic factors on the liability to develop AUD may be explained in part by dietary factors such as LC x-3 fatty acid levels. Further, these data strongly suggest that genetic variation in lipid metabolism machinery may be important in predisposing people to AUD and is worthy of further study.
